AMCI Acquisition Corp. II (AMCI) Closes LanzaTech Deal
by Nicholas Alan Clayton on 2023-02-09 at 7:26am

AMCI Acquisition Corp. II (NASDAQ:AMCI) announced this morning that it has closed its combination with carbon capture technology company LanzaTech.

The combined company’s shares are expected to begin trading on the Nasdaq on February 10 under the symbol “LNZA” and its warrants as “LNZAW”.

AMCI II shareholders approved the combination on February 6, but the SPAC noted certain closing conditions had not been satisfied at the time. It did, however, announce a $5 million addition to the transaction’s PIPE, bringing that facility to $185 million in value with the minimum cash condition set at $230 million.

The parties’ press release this morning notes that the deal is bringing in $240 million in total proceeds at close, and a post-announcement forward purchase agreement that AMCI II arranged to backstop shares could have contributed to the SPAC meeting the mark.

AMCI II inked its $1.8 billion deal with LanzaTech in March 2022. The Chicago-based company is developing carbon-capture plants designed to provide a number of carbon negative outputs ranging from jet fuel to consumer packaging materials.

At announcement, LanzaTech projected it would generate $178 million in revenue in 2023E and achieve EBITDA positivity in 2024E with $80 million in EBITDA from $436 million revenue.


ADVISORS

  • Evercore Group L.L.C. is serving as exclusive financial advisor to AMCI.
  • Barclays Capital Inc. is serving as exclusive financial advisor and capital markets advisor to LanzaTech.
  • Goldman Sachs & Co. LLC, Barclays Capital Inc. and Evercore Group L.L.C. are serving as placement agents for the PIPE transaction for AMCI.
  • Evercore Group L.L.C. and Goldman Sachs & Co. LLC are serving as capital markets advisors to AMCI.
  • White & Case LLP is serving as legal advisor to AMCI.
  • Covington & Burling LLP is serving as legal advisor to LanzaTech.
  • Ropes & Gray LLP is serving as legal advisor to the placement agents.
Recent Posts
by Kristi Marvin on 2024-10-26 at 10:00am

Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced.  That brings October’s tally to seven IPOs with one more...

by Nicholas Alan Clayton on 2024-10-25 at 8:15am

At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...

by Nicholas Alan Clayton on 2024-10-24 at 11:54am

DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...

by Nicholas Alan Clayton on 2024-10-24 at 10:18am

Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...

by Nicholas Alan Clayton on 2024-10-24 at 8:30am

At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved